ADMA Biologics Inc (ADMA) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Adma Biologics Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.274 At this time, all participants are in a listen-only mode. 00:00:03.274 -- 00:00:06.317 There will be a question and answer session to follow. 00:00:06.317 -- 00:00:09.920 Please be advised that this call is being recorded at the company's request and will 00:00:09.920 -- 00:00:13.523 be available on the company's website approximately two hours following the end of the 00:00:13.523 -- 00:00:14.964 call. 00:00:14.964 -- 00:00:17.366 At this time, I would like to introduce the company. 00:00:17.366 -- 00:00:19.747 Please go ahead. 00:00:20.809 -- 00:00:25.553 Welcome, everyone, and thank you for joining us this afternoon to discuss Admin Biologics' 00:00:25.553 -- 00:00:30.492 financial results for the third quarter of 2025 and recent corporate updates. 00:00:30.492 -- 00:00:36.218 I'm joined today by Adam Grossman, President and Chief Executive Officer, and Brad Tade, 00:00:36.218 -- 00:00:41.664 Chief Financial Officer and Treasurer. During today's call, Adam will provide some introductory 00:00:41.664 -- 00:00:46.329 comments and provide an update on corporate progress, and then Brad will provide an overview 00:00:46.329 -- 00:00:49.913 of the company's third quarter 2025 financial results. 00:00:49.913 -- 00:00:54.337 Finally, Adam will then provide some brief summary remarks before opening up the call 00:00:54.337 -- 00:00:59.741 for questions. Earlier today, we issued a press release detailing the third quarter 2025 00:00:59.741 -- 00:01:04.868 financial results and summarized certain achievements in recent corporate updates. 00:01:04.868 -- 00:01:09.292 The release is available on our website at www.admobiologics.com. 00:01:10.857 -- 00:01:14.863 Before we begin our formal comments, I'll remind you that we will be making forwa...